运动员心血管影像评估:CMR、CCT与核医学临床应用共识
本共识由欧洲预防心脏病学会与欧洲心血管影像学会联合制定,针对运动员心血管评估中的高级影像应用。共识阐述心血管磁共振、心脏CT与核医学在结构、功能、冠脉解剖、组织特征、灌注与炎症评估中的互补作用。强调标准化方案、审慎报告及功能影像在返场决策中的核心地位,以平衡运动安全与避免不必要限制。
要点
- 整合高级影像可提升运动员室性心律失常、心肌病、冠脉异常、炎症及冠心病的诊断与危险分层。
- 解读影像须区分生理性心脏重塑与病理性改变,避免误判导致不当限制运动。
- 功能性影像评估缺血或炎症,是指导运动员返场决策的核心依据。
核心结论
- 高级心血管影像作为二线检查,在临床与一线检查基础上,可提高运动员常见心脏异常的诊断精度与危险分层。
- 标准化成像方案需根据运动员年龄、训练背景及临床指征进行调整,以确保结果可靠并避免将生理适应误判为疾病。
- 共识提倡审慎报告诊断结果,充分考虑其对运动表现及法律层面的影响,仅在合理依据时推荐二线影像检查。
研究设计与样本
- 本文为欧洲预防心脏病学会(EAPC)与欧洲心血管影像学会(EACVI)联合制定的临床共识声明。
- 针对运动员群体,围绕心血管磁共振、心脏CT及核医学成像在运动心脏病学中的应用提出多模态方法。
- 共识由相关领域专家基于现有证据与临床实践制定,旨在提供标准化、安全且审慎的影像应用建议。
关键影像表现/征象
- 心血管磁共振可提供心脏结构、功能与组织特征信息,用于评估心肌病、炎症性心肌疾病及心肌纤维化等。
- 心脏CT可评估冠状动脉解剖,用于识别先天性冠状动脉异常及冠状动脉疾病。
- 核医学成像可评估心肌灌注与缺血,以及心肌炎症活动。
诊断标准与关键数值
- 建议将高级心血管影像作为二线检查,用于一线检查与临床评估后诊断仍不明确的运动员。
- 成像方案须依据运动员的年龄、训练水平与具体临床指征进行个体化调整。
- 功能成像所显示的缺血或炎症,是参与返场决策的核心依据。
临床应用与阅片要点
- 日常阅片与报告中,应结合临床与一线检查结果解读高级影像,重点关注结构、功能、灌注与炎症的整合信息。
- 报告应审慎措辞,考虑到诊断结论对运动员职业生涯及法律层面的潜在影响。
- 解读时应特别注意区分长期训练导致的生理性重塑与早期病理性改变,避免过度诊断。
局限性
- 不同运动亚组间规范数据有限,影响参考值的建立与比较。
- 细微组织异常在运动员中的临床意义尚不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The number of individuals engaging in sports continues to rise, and identifying those with cardiac substrates associated with increased risk of exercise-related adverse events is crucial. Athlete evaluation requires a refined diagnostic strategy to distinguish physiological cardiac remodelling from pathology. This joint European Association of Preventive Cardiology/European Association of Cardiovascular Imaging consensus provides a multimodality approach for advanced cardiovascular imaging in sports cardiology. Cardiovascular magnetic resonance, cardiac computed tomography, and nuclear imaging each offer complementary insights into cardiac structure, function, coronary anatomy, tissue characterization, perfusion, and inflammation. When integrated with clinical data and first-line tests, they improve diagnostic precision and risk stratification in scenarios frequently encountered in athletes, including ventricular arrhythmias, cardiomyopathies, congenital coronary anomalies, inflammatory myocardial disease, and coronary artery disease. Standardized protocols tailored to age, training, and clinical indication are essential to ensure reliability and avoid misinterpreting physiological adaptation as disease. The consensus emphasizes responsible reporting, considering performance and legal implications of diagnoses, and recommends second-line imaging when justified. Functional imaging, for ischaemia or inflammation, is central in guiding return-to-play decisions. Persistent evidence gaps include limited normative datasets across athletic subgroups and uncertain significance of subtle tissue abnormalities. Overall, this consensus supports harmonized, safe, and judicious multimodality imaging to protect athletes while preventing unnecessary sport restriction.
引用
- Maestrini, Gati, D'Ascenzi, et al. Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes: a clinical consensus statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC), Part 2: Cardiovascular magnetic resonance, cardiac CT, and nuclear imaging. Eur J Prev Cardiol. 2026. PMID: 42332984. doi:10.1093/eurjpc/zwag241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。